Early phase trials conducted in Croatia for inflammatory bowel disease reported safety with no toxicity, but detailed data never appeared in peer-reviewed literature
From a compounding-access standpoint, deferral is functionally indistinguishable from a no the bulks list doesnt change
Emerging options include survodutide , orforglipron (an oral GLP-1 in late-stage trials), and mazdutide
The medications slow gastric emptying and quiet appetite signals, which helps with weight management and glucose control
The weight loss drug boom is here, and even retailers like Walmart $WMT are starting to feel the pressure to compete
Gather your medical records, prescription history, and a written account of your symptoms and treatment timeline